rs587783991
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP2PP3_ModeratePP5
The NM_133433.4(NIPBL):c.6068A>G(p.His2023Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_133433.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NIPBL | ENST00000282516.13 | c.6068A>G | p.His2023Arg | missense_variant | Exon 34 of 47 | 1 | NM_133433.4 | ENSP00000282516.8 | ||
NIPBL | ENST00000448238.2 | c.6068A>G | p.His2023Arg | missense_variant | Exon 34 of 46 | 1 | ENSP00000406266.2 | |||
NIPBL | ENST00000652901.1 | c.6068A>G | p.His2023Arg | missense_variant | Exon 34 of 46 | ENSP00000499536.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Cornelia de Lange syndrome 1 Pathogenic:1Uncertain:1
This sequence change replaces histidine, which is basic and polar, with arginine, which is basic and polar, at codon 2023 of the NIPBL protein (p.His2023Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with NIPBL-related conditions (internal data). ClinVar contains an entry for this variant (Variation ID: 159170). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt NIPBL protein function with a positive predictive value of 95%. This variant disrupts the p.His2023 amino acid residue in NIPBL. Other variant(s) that disrupt this residue have been observed in individuals with NIPBL-related conditions (PMID: 25125236), which suggests that this may be a clinically significant amino acid residue. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at